EG SA
162.0 FTEEG reported revenue of €263.2m for the 2025 financial year (annual accounts filed with the NBB on 25 Aug 2026), with 162 full-time equivalents.
The score of EG shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue +9 % Equity +4 % Total assets -8 % Headcount (avg FTE) 0 %
Accounts of the company itself (not consolidated).
The full file covers 17 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
EG's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | €263.2m | ||||
| Net result | €29.6m | ||||
| Equity | €61.3m | ||||
| Cash | €43.9m | ||||
| EBITDA | €40.8m | ||||
| Total assets | €113.6m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 25 Aug 2026
- Year ended 31 Dec 2024filed on 26 Jun 2025
- Year ended 31 Dec 2023filed on 25 Jun 2024
- Year ended 31 Dec 2022filed on 31 Jul 2023
- Year ended 31 Dec 2021filed on 29 Jun 2022
EG's financial analysis
- Solvency54.0%sector median: 32.3%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of EG
EG's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0419.806.694
- VAT number
- BE0419806694
- Peppol
- Registered · 0208:0419806694 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 02 Oct 1979
- Registered office
- 1020 Brussels
- Size
- Medium · 162.0 FTE
- Latest accounts
- 2025 · filed on 25 Aug 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
EG (SA) has been based in Brussels since 1979, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports revenue of €263.2m, a net profit of €29.6m and equity of €61.3m. With 162.0 full-time equivalents, it is a medium-sized enterprise by headcount. Its solvency stands at 54.0%, above the median of its sector (32.3%).
Companies similar to EG
Companies in the same business, of comparable size and area, outside its group.
- Gilead Sciences Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €68.7m
- sandoz Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €55.3m
- Menarini Benelux Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €48.6m
- Novartis Pharma Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €168.8m
- Recordati Wholesale of pharmaceutical and medical goods Jette · balance sheet €20.8m
- Biogen Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €25.5m
- Vertex Pharmaceuticals (Belgium) Wholesale of pharmaceutical and medical goods Brussels · balance sheet €84.4m
- Takeda Belgium Wholesale of pharmaceutical and medical goods Zaventem · balance sheet €86.4m
Frequently asked questions about EG
What is the revenue of EG?
According to the 2025 annual accounts filed with the NBB, the revenue of EG amounts to 263,150,627 €.
What is the VAT number of EG?
In Belgium, the VAT number is the company number prefixed with BE: BE0419806694 for EG, if the company is VAT-registered. Its company number (CBE) is 0419.806.694.
Where is the registered office of EG?
According to the CBE register, the registered office of EG is in 1020 Brussels.
What is the equity of EG?
At the close of the 2025 financial year, the equity of EG amounts to 61,309,512 €, a solvency of 54.0% of total assets.
How many people work at EG?
162.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages EG?
The register lists 3 active mandates at EG. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of EG
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →